From: sfbrph <sfbrph@...>
Subject: [chinastemcells] Re: Salt Lake researchers launch groundbreaking stem cell study
To: chinastemcells@yahoogroups.com
Date: Thursday, January 1, 2009, 10:20 PM

Hi Drew. This is Brad who was with you in Hangzhou. How are you
doing man? You taking care of Chris? Happy New Year 2009!

--- In chinastemcells@ yahoogroups. com, drew schemera <schemera@.. .>
wrote:
>
>
>
>
>
>
>
>
>
>
> Make it a great day!,
> Drew
>  
> Drew J.Schemera III
>
> Spine Implant Territory Rep.
> New York Metro/Long Island/CT
> Cell-914.621. 1291
> Fax-203.329. 0461
>
> --- On Tue, 10/7/08, Susan Boden <sfbrph@...> wrote:
>
> From: Susan Boden <sfbrph@...>
> Subject: Re: [chinastemcells] Salt Lake researchers launch
groundbreaking stem cell study
> To: chinastemcells@ yahoogroups. com
> Date: Tuesday, October 7, 2008, 6:45 PM
>
>
>
>
>
>
>
> Drew,
>  
> Brad, an ataxia patient, and me (susan) are here now. 10/3-10/29 
Brad is scheduled to have 4 SCT & 1 BMT  We are in room 3 and look
forward to meeting you
>
>
> --- On Sun, 10/5/08, drew schemera <schemera@.. .> wrote:
>
> From: drew schemera <schemera@.. .>
> Subject: Re: [chinastemcells] Salt Lake researchers launch
groundbreaking stem cell study
> To: stemcellsafety@ yahoogroups. com, chinastemcells@ yahoogroups. com
> Date: Sunday, October 5, 2008, 6:25 PM
>
>
>
>
>
>
> is anyone going to be in hangzhou oct 19- nov 19?
> REGARDS
> DREW
> USA
>
>
>
>
>
>
>
>
> Make it a great day!,
> Drew
>  
> Drew J.Schemera III
>
> Spine Implant Territory Rep.
> New York Metro/Long Island/CT
> Cell-914.621. 1291
> Fax-203.329. 0461
>
> --- On Fri, 10/3/08, Kirshner Ross-Vaden <kirsh@...> wrote:
>
> From: Kirshner Ross-Vaden <kirsh@...>
> Subject: [chinastemcells] Salt Lake researchers launch
groundbreaking stem cell study
> To: stemcellsafety@ yahoogroups. com, chinastemcells@ yahoogroups. com
> Date: Friday, October 3, 2008, 8:33 AM
>
>
>
>
>
>
> What I would like everyone to not in this article are the areas in
red.
> ·       A special kind of adult stem cell taken from the bone
marrow of living donors will be injected into the blood stream
shortly after their heart surgeries.
> ·       The stem cells don't even have to match the patient's
blood type.
>
> ·       "The beauty of these cells that have been developed is
that they'll home in on whatever organ has the injury," Doty said.
>
>
> Salt Lake researchers launch groundbreaking stem cell study
>   Updated: 10/2/2008 7:08:25 AM    Posted: 10/2/2008 7:06:01 AM
> ·                                  
>  
> Salt Lake researchers are launching a groundbreaking clinical
trial, the first of its kind in the world, to see if adult stem cell
transplants will reverse or prevent kidney failure.
>
> If it works, it will be the kind of self-healing everybody has
been waiting for.
>
> The transplants have proven successful in animal experiments in
Germany and Salt Lake .
>
> Now it's time to start clinical trials in humans.
>
> Two patients here have already had the transplants.
>
> Open heart surgery places a lot of stress on the kidneys.
>
> Patients who already have other multiple complications often go
into kidney failure.
>
> That's why this group has been selected for the clinical trial.
>
> A special kind of adult stem cell taken from the bone marrow of
living donors will be injected into the blood stream shortly after
their heart surgeries.
>
> John Doty, M.D., with the Intermountain Medical Center, said, "We
take a small catheter, place that through the blood vessels of the
leg, up into the descending thoracic aorta and then inject the stem
cells under sterile conditions over about a minute."
>
> The stem cells don't even have to match the patient's blood type.
>
> They'll be kept frozen until needed, then processed at the
University of Utah 's cell therapy lab using a technique developed
by a Salt Lake biotech company called Allocure.
>
> Inside the blood stream, the stem cells wait for the damaged or
failing kidney to call for help.
>
> Christof Westenfelder, M.D., the Chief Medical Officer at
Allocure, said, "These cells then, after they read what's going on
in the injured organ, they then instruct the surviving cells in the
injured organ to defend themselves, to repair the organ."
>
> The stem cells linger until the repair is complete, then, as
programmed, self-destruct within three days so they won't go to
other organs where they're not needed.
>
> While this first phase clinical trial is for kidneys and is
testing safety only, imagine what's next, the possibilities!
>
> "The beauty of these cells that have been developed is that
they'll home in on whatever organ has the injury," Doty said.
>
> Those other organs could include the heart, lungs, liver and eyes.
>
> These cells could prove very therapeutic for disease like
diabetes.
>  
>